Efficacy of lavender in the treatment of fatigue in patients with multiple sclerosis
Not Applicable
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20190710044166N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Definitive diagnosis of MS according to McDonald's criteria and confirmed by a neurologist
Relapsing-remitting type of MS
Having symptoms of fatigue
Expanded Disability Status Score (EDSS) of less than or equal to 6
No disease attack during the last month
Not using other medication during the study
No Depression disease Based on Beck Questionnaire
No history of other diseases such as autoimmune disease, malignancy
No usind of drugs such as antipsychotic , monoamine oxidase inhibitors, benzodiazepines, tricyclic antidepressants, anticonvulsants and barbiturates
Exclusion Criteria
Disease attack during the study
The emergence of drug complications
Not willingness to continue the study
Pregnancy
Breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue score on the MFIS questionnaire. Timepoint: At baseline and two months after drug administration. Method of measurement: MFIS questionnaire.
- Secondary Outcome Measures
Name Time Method